期刊
VACCINES
卷 3, 期 3, 页码 620-637出版社
MDPI
DOI: 10.3390/vaccines3030620
关键词
recombinant plant virus; vaccine; adjuvant; immune response; production methods
资金
- Canadian Institutes of Health Research [MOP-89833]
- Jeanne and J.-Louis Levesque Chair in Immunovirology from the J.-Louis Levesque Foundation
- Fonds de Recherche Sante Quebec
Vaccines are considered one of the greatest medical achievements in the battle against infectious diseases. However, the intractability of various diseases such as hepatitis C, HIV/AIDS, malaria, tuberculosis, and cancer poses persistent hurdles given that traditional vaccine-development methods have proven to be ineffective; as such, these challenges have driven the emergence of novel vaccine design approaches. In this regard, much effort has been put into the development of new safe adjuvants and vaccine platforms. Of particular interest, the utilization of plant virus-like nanoparticles and recombinant plant viruses has gained increasing significance as an effective tool in the development of novel vaccines against infectious diseases and cancer. The present review summarizes recent advances in the use of plant viruses as nanoparticle-based vaccines and adjuvants and their mechanism of action. Harnessing plant-virus immunogenic properties will enable the design of novel, safe, and efficacious prophylactic and therapeutic vaccines against disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据